Expression of cysteine proteases in extraembryonic tissues during mouse embryogenesis

被引:19
作者
Sol-Church, K [1 ]
Shipley, J [1 ]
Beekman, DA [1 ]
Mason, RW [1 ]
机构
[1] Alfred I Dupont Hosp Children, Dept Res, Enzymol Lab, Wilmington, DE 19803 USA
关键词
cathepsin; inhibitor; placenta; visceral yolk sac; cysteine protease; ribonuclease protection assay;
D O I
10.1006/abbi.1999.1520
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The expression of cathepsin B- and L-specific mRNAs as well as active forms of the enzymes was determined in mouse placenta and visceral yolk, sac from 7.5 through 17.5 days postconception, a period marked by major anatomic transitions in the mouse conceptus. The level of specific mRNA was determined relative to the 28S ribosomal RNA in a series of multiprobe ribonuclease protection assays using high-specific-activity antisense cathepsin B and L riboprobes. The molecular forms of active cysteine proteases present in the tissues at the time of extraction were detected using a membrane-permeant radiolabeled active site-specific inhibitor, Fmoc-[I-125(2)]Tyr-Ala-CHN2. The results of this study show that the expression of active cathepsin L relative to active cathepsin B is significantly higher in visceral yolk sac than in placenta, consistent with a higher proteolytic requirement for the former tissue. Active cathepsin L was highest at Day 9.5 in visceral yolk sac, a stage at which it has been shown that proteolysis in this organ is required for production of amino acids for embryonic protein synthesis. Cathepsin L mRNA was also elevated in the Day 9.5 placenta, but paradoxically this did not result in an increase in cellular active enzyme. An unknown protein, termed p14, highly expressed in placenta, also reacted with the inhibitor, Expression of this protein was highest early during gestation in the ectoplacental cone, suggesting that p14 may be important in the implantation process. (C) 1999 Academic Press.
引用
收藏
页码:375 / 381
页数:7
相关论文
共 20 条
[1]  
Afonso S, 1997, DEVELOPMENT, V124, P3415
[2]   IN-VITRO EMBRYOTOXICITY OF THE CYSTEINE PROTEINASE-INHIBITORS BENZYLOXYCARBONYL-PHENYLALANINE-ALANINE-DIAZOMETHANE (Z-PHE-ALA-CHN2) AND BENZYLOXYCARBONYL-PHENYLALANINE-PHENYLALANINE-DIAZOMETHANE (Z-PHE-PHE-CHN2) [J].
AMBROSO, JL ;
HARRIS, C .
TERATOLOGY, 1994, 50 (03) :214-228
[3]   Sources of amino acids for protein synthesis during early organogenesis in the rat .4. Mechanisms before envelopment of the embryo by the yolk sac [J].
Beckman, DA ;
Brent, RL ;
Lloyd, JB .
PLACENTA, 1996, 17 (08) :635-641
[4]  
CAMPO E, 1994, AM J PATHOL, V145, P301
[5]   ENZYMATICALLY ACTIVE LYSOSOMAL PROTEASES ARE ASSOCIATED WITH AMYLOID DEPOSITS IN ALZHEIMER BRAIN [J].
CATALDO, AM ;
NIXON, RA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (10) :3861-3865
[6]   NUCLEOTIDE AND PREDICTED AMINO-ACID-SEQUENCES OF CLONED HUMAN AND MOUSE PREPROCATHEPSIN-B CDNAS [J].
CHAN, SJ ;
SANSEGUNDO, B ;
MCCORMICK, MB ;
STEINER, DF .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1986, 83 (20) :7721-7725
[7]   EFFECTS OF LYSOSOMAL PROTEINASE INHIBITION ON THE DEVELOPMENT OF THE RAT EMBRYO INVITRO [J].
DASTON, GP ;
BAINES, D ;
YONKER, JE ;
LEHMANMCKEEMAN, LD .
TERATOLOGY, 1991, 43 (03) :253-261
[8]  
Delaisse Jean-Marie, 1992, P289
[9]   Cathepsins B and D are dispensable for major histocompatibility complex class II-mediated antigen presentation [J].
Deussing, J ;
Roth, W ;
Saftig, P ;
Peters, C ;
Ploegh, HL ;
Villadangos, JA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (08) :4516-4521
[10]  
FREEMAN SJ, 1981, J EMBRYOL EXP MORPH, V66, P223